337 related articles for article (PubMed ID: 28090210)
21. Stem cells in kidney diseases.
Soler MJ; José Tomas OP
J Stem Cells; 2012; 7(4):245-59. PubMed ID: 24196799
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
Hamada H; Kim MK; Iwakura A; Ii M; Thorne T; Qin G; Asai J; Tsutsumi Y; Sekiguchi H; Silver M; Wecker A; Bord E; Zhu Y; Kishore R; Losordo DW
Circulation; 2006 Nov; 114(21):2261-70. PubMed ID: 17088460
[TBL] [Abstract][Full Text] [Related]
23. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway.
Everaert BR; Van Craenenbroeck EM; Hoymans VY; Haine SE; Van Nassauw L; Conraads VM; Timmermans JP; Vrints CJ
Int J Cardiol; 2010 Oct; 144(3):350-66. PubMed ID: 20444511
[TBL] [Abstract][Full Text] [Related]
24. BM ageing: Implication for cell therapy with EPCs.
Rurali E; Bassetti B; Perrucci GL; Zanobini M; Malafronte C; Achilli F; Gambini E
Mech Ageing Dev; 2016 Oct; 159():4-13. PubMed ID: 27045606
[TBL] [Abstract][Full Text] [Related]
25. A Chemokine Receptor, CXCR4, Which Is Regulated by Hypoxia-Inducible Factor 2α, Is Crucial for Functional Endothelial Progenitor Cells Migration to Ischemic Tissue and Wound Repair.
Tu TC; Nagano M; Yamashita T; Hamada H; Ohneda K; Kimura K; Ohneda O
Stem Cells Dev; 2016 Feb; 25(3):266-76. PubMed ID: 26620723
[TBL] [Abstract][Full Text] [Related]
26. Endothelial progenitor cells: therapeutic target for cardiovascular diseases.
Umemura T; Higashi Y
J Pharmacol Sci; 2008 Sep; 108(1):1-6. PubMed ID: 18776710
[TBL] [Abstract][Full Text] [Related]
27. Progenitor cells and vascular function are impaired in patients with chronic kidney disease.
Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC
Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases.
Dzau VJ; Gnecchi M; Pachori AS; Morello F; Melo LG
Hypertension; 2005 Jul; 46(1):7-18. PubMed ID: 15956118
[TBL] [Abstract][Full Text] [Related]
29. Highly efficient local delivery of endothelial progenitor cells significantly potentiates angiogenesis and full-thickness wound healing.
Wang C; Wang Q; Gao W; Zhang Z; Lou Y; Jin H; Chen X; Lei B; Xu H; Mao C
Acta Biomater; 2018 Mar; 69():156-169. PubMed ID: 29397318
[TBL] [Abstract][Full Text] [Related]
30. A preventive injection of endothelial progenitor cells prolongs lifespan in stroke-prone spontaneously hypertensive rats.
Peng C; Dong XH; Liu JL; Tao YL; Xu CF; Wang LP; Liu CL; Su DF; Tao X; Zhang C; Chen AF; Xie HH
Clin Sci (Lond); 2018 Aug; 132(16):1797-1810. PubMed ID: 30006482
[TBL] [Abstract][Full Text] [Related]
31. Endothelial progenitor cells as the target for cardiovascular disease prediction, personalized prevention, and treatments: progressing beyond the state-of-the-art.
Kou F; Zhu C; Wan H; Xue F; Wang J; Xiang L; Li J
EPMA J; 2020 Dec; 11(4):629-643. PubMed ID: 33240451
[TBL] [Abstract][Full Text] [Related]
32. Dickkopf-1 Treatment Stimulates Hematopoietic Regenerative Function in Infused Endothelial Progenitor Cells.
Kim MM; Schlussel L; Zhao L; Himburg HA
Radiat Res; 2019 Jul; 192(1):53-62. PubMed ID: 31081743
[TBL] [Abstract][Full Text] [Related]
33. Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis.
Lee DY; Cho TJ; Kim JA; Lee HR; Yoo WJ; Chung CY; Choi IH
Bone; 2008 May; 42(5):932-41. PubMed ID: 18326482
[TBL] [Abstract][Full Text] [Related]
34. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
Sen S; McDonald SP; Coates PT; Bonder CS
Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
[TBL] [Abstract][Full Text] [Related]
35. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
Kawamoto A; Asahara T
Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
Cheng Y; Hu R; Lv L; Ling L; Jiang S
J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
[TBL] [Abstract][Full Text] [Related]
37. Hypoxic preconditioning-induced autophagy enhances survival of engrafted endothelial progenitor cells in ischaemic limb.
Zhou P; Tan YZ; Wang HJ; Wang GD
J Cell Mol Med; 2017 Oct; 21(10):2452-2464. PubMed ID: 28374977
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia inhibits cellular senescence to restore the therapeutic potential of old human endothelial progenitor cells via the hypoxia-inducible factor-1α-TWIST-p21 axis.
Lee SH; Lee JH; Yoo SY; Hur J; Kim HS; Kwon SM
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2407-14. PubMed ID: 23928864
[TBL] [Abstract][Full Text] [Related]
39. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model.
Schuh A; Liehn EA; Sasse A; Hristov M; Sobota R; Kelm M; Merx MW; Weber C
Basic Res Cardiol; 2008 Jan; 103(1):69-77. PubMed ID: 17999028
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via PI3K/Akt pathway.
Hu R; Cheng Y; Jing H; Wu H
Shock; 2014 Oct; 42(4):327-36. PubMed ID: 25051281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
